Publisher Correction: Efficacy and safety of praziquantel combined with artemisinin derivatives versus praziquantel monotherapy for schistosomiasis: a meta-analysis of randomized controlled trials.

This publisher correction addresses errors in a previously published meta-analysis comparing the efficacy and safety of praziquantel (PZQ) combined with artemisinin derivatives (ARTs) versus praziquantel monotherapy for schistosomiasis. The correction includes the addition of a missing figure (Figur...

Descripción completa

Detalles Bibliográficos
Publicado en:Infection pp. 1 - 7
Autores principales: Yang, Yao, Meng, Jiahao, Li, Chunhui, Liu, Pan, Wu, Yumei, Wang, Xuanyu, Xia, Zhuoyang, Gao, Shuguang
Formato: Journal Article
Publicado: Springer Nature Jun2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194472361&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 194472361
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        03008126
        NXO
      jtl: Infection
      issn: 03008126
      maglogo: N
    pubinfo:
      dt: Jun2026
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        194472361
        10.1007/s15010-026-02851-6
        194472361
      ppf: 1
      ppct: 6
      formats:
      tig:
        atl: Publisher Correction: Efficacy and safety of praziquantel combined with artemisinin derivatives versus praziquantel monotherapy for schistosomiasis: a meta-analysis of randomized controlled trials.
      aug:
        au:
          Yang, Yao
          Meng, Jiahao
          Li, Chunhui
          Liu, Pan
          Wu, Yumei
          Wang, Xuanyu
          Xia, Zhuoyang
          Gao, Shuguang
        affil: Department of Orthopaedics, Xiangya Hospital, Central South University
      sug:
      ab: This publisher correction addresses errors in a previously published meta-analysis comparing the efficacy and safety of praziquantel (PZQ) combined with artemisinin derivatives (ARTs) versus praziquantel monotherapy for schistosomiasis. The correction includes the addition of a missing figure (Figure 2) related to the risk of bias assessment and the renumbering of Figures 3 through 8, which present meta-analytic findings on cure rates, egg count reduction, and adverse event incidence. The original article has been updated to reflect these corrections.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Unknown
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N